Communications Medicine (May 2024)

Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer

  • Daan G. Knapen,
  • Sara Hone Lopez,
  • Derk Jan A. de Groot,
  • Jacco-Juri de Haan,
  • Elisabeth G. E. de Vries,
  • Rodrigo Dienstmann,
  • Steven de Jong,
  • Arkajyoti Bhattacharya,
  • Rudolf S. N. Fehrmann

DOI
https://doi.org/10.1038/s43856-024-00504-z
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Bulk transcriptional profiles of early colorectal cancer (CRC) can fail to detect biological processes associated with disease-free survival (DFS) if the transcriptional patterns are subtle and/or obscured by other processes’ patterns. Consensus-independent component analysis (c-ICA) can dissect such transcriptomes into statistically independent transcriptional components (TCs), capturing both pronounced and subtle biological processes. Methods In this study we (1) integrated transcriptomes (n = 4228) from multiple early CRC studies, (2) performed c-ICA to define the TC landscape within this integrated data set, 3) determined the biological processes captured by these TCs, (4) performed Cox regression to identify DFS-associated TCs, (5) performed random survival forest (RSF) analyses with activity of DFS-associated TCs as classifiers to identify subgroups of patients, and 6) performed a sensitivity analysis to determine the robustness of our results Results We identify 191 TCs, 43 of which are associated with DFS, revealing transcriptional diversity among DFS-associated biological processes. A prominent example is the epithelial-mesenchymal transition (EMT), for which we identify an association with nine independent DFS-associated TCs, each with coordinated upregulation or downregulation of various sets of genes. Conclusions This finding indicates that early CRC may have nine distinct routes to achieve EMT, each requiring a specific peri-operative treatment strategy. Finally, we stratify patients into DFS patient subgroups with distinct transcriptional patterns associated with stage 2 and stage 3 CRC.